venBio Partners
Highly Engaged Employees
Highly Engaged EmployeesFinance · California, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
1700 Owens St Ste 595, San Francisco, Ca...Phone Number
(415) 800-0800Website
www.venbio.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
2
2
2
1
1
About venBio Partners
venBio is a life sciences investment firm that partners with industry leaders to develop innovative medicines and technologies, focusing on novel therapeutics for unmet medical needs. Founded in 2011, the firm manages nearly $1.1 billion in committed capital and emphasizes the importance of positioning its portfolio companies for potential acquisition. venBio's mission is to support teams in creating impactful treatments that enhance patient care by providing strategic guidance on development plans. The firm fosters lasting relationships with leaders in the industry to ensure successful outcomes for their investments.Explore more
venBio Partners Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is venBio Partners your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on venBio Partners recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at venBio Partners
Check out if venBio Partners is spiking on competitors!
Product Launch: Get notified when venBio Partners launches new products
Click to see if venBio Partners had a recent Job posting/layoffs
Funding: Get notified immidiatlly once venBio Partners has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
venBio Partners, which may be a good buyer, showed buying intent in Masked Content Topic
Check if venBio Partners has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Compare Similar Companies to venBio Partners
Compare insights from companies similar to venBio Partners, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
venBio Partners is experiencing very low activity levels compared to other companies in the Finance sector.
What does this means?
venBio Partners is drawing exceptional interest within the Finance industry, suggesting notable developments or strong market momentum, learn more about venBio Partners.
venBio Partners Tech Stack
A closer look at the technologies used by venBio Partners
Most Recent Scoops
Project
Spending/Investment
Project
Spending/Investment
Project
Spending/Investment
Project
Spending/Investment
Project
Spending/Investment
venBio Partners News & Media
Lexeo Therapeutics, Perceptive Xontogeny Venture Funds and venBio Partners Announce Partnership to Advance Novel Cardiac RNA Therapeutics
Lexeo Therapeutics, Perceptive Xontogeny Venture Funds and venBio Partners Announce Partnership to Advance Novel Cardiac RNA TherapeuticsAxonis Therapeutics Announces $115 Million Series A Financing
-- Oversubscribed financing brings together leading syndicate of life sciences investors -- -- Proceeds to support clinical development of first-in-class therapies for neurological disorders – BOSTON, Oct. 30, 2024 /PRNewswire/ -- Axonis Therapeutics, a biotechnology company focused on...Vicebio Announces $100 Million Series B Financing and Initiation of Phase 1 Clinical Study of RSV/hMPV Bivalent Vaccine
Financing led by new investor TCGX, alongside Goldman Sachs Alternatives, Avoro Ventures and venBio Funding will support and accelerate development of next-generation multivalent respiratory virus vaccines using proprietary Molecular Clamp technology Commenced Phase I clinical study of...venBio raises $528 million for its fifth fund - STAT News
Today's biotech news updates include Zepbound benefits in heart failure, Regenxbio's Duchenne therapy, and earnings from Biogen, Apellis, etc.
Read more news
Top Finance Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding venBio Partners
Sign Up For FreeTo access detailed company insights
venBio is a life sciences investment firm that partners with industry leaders to develop innovative medicines and technologies, focusing on novel therapeutics for unmet medical needs. Founded in 2011, the firm manages nearly $1.1 billion in committed capital and emphasizes the importance of positioning its portfolio companies for potential acquisit... Read More
